{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:51Z","timestamp":1792097391420,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.oooo.2026.09.005","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:18:17Z","timestamp":1790147897000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary mandibular ALK-positive anaplastic large cell lymphoma in a 5-year-old child: a case report and review of the literature"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1557-3209","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Alarc\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8208-0435","authenticated-orcid":false,"given":"Claudio","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00edn","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Venables","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2026.09.005_bib0001","series-title":"Haematolymphoid tumours","year":"2024"},{"key":"10.1016\/j.oooo.2026.09.005_bib0002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41568-020-0247-0","article-title":"Peripheral T cell lymphomas: from the bench to the clinic","volume":"20","author":"Fiore","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.oooo.2026.09.005_bib0003","doi-asserted-by":"crossref","first-page":"6951","DOI":"10.1128\/MCB.18.12.6951","article-title":"Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity","volume":"18","author":"Bai","year":"1998","journal-title":"Mol Cell Biol"},{"issue":"19","key":"10.1016\/j.oooo.2026.09.005_bib0004","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.3390\/cancers17193138","article-title":"Primary aggressive oral lymphomas (PAOL): a narrative review of diagnosis, molecular features, therapeutic approaches, and the integrated role of dentists and hematologists","volume":"17","author":"Bibas","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.oooo.2026.09.005_bib0005","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2026.09.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.85","article-title":"Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions","volume":"7","author":"van der Weyden","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.oooo.2026.09.005_bib0007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/bloodadvances.2020001581","article-title":"ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the international T-cell project","volume":"5","author":"Shustov","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.oooo.2026.09.005_bib0008","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/ejh.12360","article-title":"Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease","volume":"93","author":"Eyre","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.oooo.2026.09.005_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2023.101444","article-title":"Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents","volume":"36","author":"Rigaud","year":"2023","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.oooo.2026.09.005_bib0010","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1007\/s00277-025-06579-5","article-title":"A comprehensive analysis of B symptoms reveals prognosis and heterogeneity across different sites of diffuse large B-cell lymphoma","volume":"104","author":"Wu","year":"2025","journal-title":"Ann Hematol"},{"key":"10.1016\/j.oooo.2026.09.005_bib0011","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/jop.13205","article-title":"Mature T\/NK-cell lymphomas of the oral and maxillofacial region: a multi-institutional collaborative study","volume":"50","author":"de Arruda","year":"2021","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.oooo.2026.09.005_bib0012","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s12105-020-01176-6","article-title":"Anaplastic large cell lymphoma with oral manifestation: a series of four cases and literature review","volume":"14","author":"de Andrade","year":"2020","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.oooo.2026.09.005_bib0013","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.tripleo.2008.05.037","article-title":"Anaplastic large cell lymphoma in gingiva: case report and literature review","volume":"106","author":"Matsumoto","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2026.09.005_bib0014","article-title":"Primary gingival anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma in a young boy","volume":"17","author":"Lutz","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.oooo.2026.09.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107452","article-title":"Alk-positive anaplastic large cell lymphoma: first documented case of primary mandibular involvement in a 12-year-old male","volume":"167","author":"Trimukhe","year":"2025","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.oooo.2026.09.005_bib0016","article-title":"ALK positive anaplastic large cell lymphoma of oral cavity: a case report","volume":"12","author":"Nili","year":"2019","journal-title":"Int J Cancer Manag"},{"issue":"10","key":"10.1016\/j.oooo.2026.09.005_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3390\/cancers9100141","article-title":"An exploration into the origins and pathogenesis of anaplastic large cell lymphoma, anaplastic lymphoma kinase (ALK)-positive","volume":"9","author":"Turner","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.oooo.2026.09.005_bib0018","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3390\/cancers14071650","article-title":"Anaplastic large cell lymphoma: molecular pathogenesis and treatment","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.oooo.2026.09.005_bib0019","doi-asserted-by":"crossref","first-page":"20852","DOI":"10.1073\/pnas.0810958105","article-title":"Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)","volume":"105","author":"Marzec","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.oooo.2026.09.005_bib0020","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1182\/bloodadvances.2024014745","article-title":"Pediatric relapsed\/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era","volume":"9","author":"Marks","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.oooo.2026.09.005_bib0021","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00277-016-2764-1","article-title":"Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety","volume":"95","author":"Chan","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.oooo.2026.09.005_bib0022","doi-asserted-by":"crossref","first-page":"607","DOI":"10.7326\/L16-0037","article-title":"Nivolumab for refractory anaplastic large cell lymphoma: a case report","volume":"165","author":"Hebart","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.oooo.2026.09.005_bib0023","first-page":"65","article-title":"Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma","author":"Rigaud","year":"2018","journal-title":"Pediatr Blood Cancer"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440326005419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440326005419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:43:21Z","timestamp":1792097001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440326005419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"alternative-id":["S2212440326005419"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2026.09.005","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary mandibular ALK-positive anaplastic large cell lymphoma in a 5-year-old child: a case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2026.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}